ReviewThe oncologist2021

FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer.

Luckson Mathieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.